A Study to Compare PK/PD Characteristics and Safety Profiles Between AD-212-A and AD-2121

NCT06025773 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastro Esophageal Reflux

Interventions

DRUG: Lansoprazole 15 mg
DRUG: Lansoprazole 15mg/Calcium carbonate 600mg

Sponsor

Addpharma Inc.